Fennec Pharmaceuticals FENC 深 沪
交易中 08-20 10:41:43 美东时间
7.68
-0.230
-2.91%
华盛通- 最 高7.88
- 今 开7.88
- 成交量 6146股
- 最 低 7.5766
- 昨 收 7.91
- 总市值 2.12亿
- 52周最高 9.42
- 市盈率 静 --
- 换手率 0.02%
- 52周最低 3.96
- 委 比 -62.72%
- 总股本 2761.87万
- 历史最高 14.986
- 量 比 0.66
- 振 幅 3.84%
- 历史最低 3.255
- 每 手 1
- 风险率 2.07%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | Macquarie维持小鹏汽车"跑赢大市"评级，目标价升至25美元
今日重点评级关注：HC Wainwright & Co.：维持BioXcel Therapeutics"买入"评级，目标价从8美元升至10美元；Craig-Hallum：维持Fennec Pharmaceuticals"买入"评级，目标价从13美元升至14美元
08-18 10:22
Fennec Pharmaceuticals shares are trading lower following a Q2 EPS miss.
Fennec Pharmaceuticals shares are trading lower following a Q2 EPS miss.
08-15 00:35
Fennec Pharmaceuticals Q2 EPS $(0.11) Misses $(0.04) Estimate, Sales $9.65M Beat $9.52M Estimate
Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.04) by 205.56 percent. This is a 45 percent increase over losses of $(0.20) per share
08-14 18:09
Earnings Scheduled For August 14, 2025
Companies Reporting Before The Bell • Sunlands Technology (NYSE:STG) is likely ...
08-14 16:32
Fennec Pharmaceuticals Earnings Preview
Fennec Pharmaceuticals (NASDAQ:FENC) will release its quarterly earnings report...
08-14 02:02
Fennec Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 14, 2025
Fennec Pharmaceuticals Inc. will release its Q2 2025 financial results on August 14, 2025, before U.S. markets open. Management will host a conference call at 8:30 a.m. EDT that day, with a live webcast available at https://edge.media-server.com/mmc/p/de4jxxzj. A replay will be archived on www.fennecpharma.com for 30 days. Fennec focuses on reducing cancer patients' cisplatin-induced hearing loss through PEDMARK®, which received FDA approval in 2...
08-11 11:12
Fennec Pharmaceuticals Approves Proposals at Shareholder Meeting
The latest update is out from Fennec Pharmaceuticals ( ($TSE:FRX) ). On June 3,...
06-04 05:03
Fennec Announces Results of Annual Meeting
Fennec Pharmaceuticals Inc. announced that all nominated directors were elected at the Annual General and Special Meeting of Shareholders held on June 3, 2025, in New York. Voting results showed strong support for each nominee, with Dr. Khalid Islam receiving 97.84% approval and Dr. Jodi Cook garnering 93.62%. Shareholders also approved the appointment of Haskell & White LLP as auditors (99.64%), the named executive officers' compensation (85.50%...
06-03 20:31
京东物流x芬驰合作再升级，温州时尚行业专仓开仓！
随着618年中大促的脚步临近，电商行业进入全年最关键的备战期。近日，国内眼镜电商头部企业芬驰眼镜与京东物流深化合作，温州时尚行业专仓暨芬驰眼镜仓正式开仓。这座坐...
05-23 19:26
美股大行评级 | 潜在涨幅300.0%！HC Wainwright & Co.：Armata Pharmaceuticals获机构升目标价至9美元，维持"买入"评级
潜在涨幅300.0%！HC Wainwright & Co.：Armata Pharmaceuticals获机构升目标价至9美元，维持"买入"评级
05-21 16:44
